4//SEC Filing
Stone Christopher Lewis 4
Accession 0000882104-18-000129
CIK 0000882104other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 6:29 PM ET
Size
6.1 KB
Accession
0000882104-18-000129
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Tax Payment
Common stock
2018-12-27$3.02/sh−3,581$10,815→ 427,206 total - Disposition to Issuer
Common stock
2018-12-27−228,255→ 198,951 total
Footnotes (1)
- [F1]Disposition of common stock due to performance criteria not being achieved under equity incentive plans.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001453373
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 6:29 PM ET
- Size
- 6.1 KB